Your browser doesn't support javascript.
loading
Cross-sectional analysis of the associations between fibromyalgia and diabetes mellitus.
Lichtenstein, Adi; Tiosano, Shmuel; Comaneshter, Doron; Amital, Howard; Cohen, Arnon D; Amital, Daniela.
Afiliação
  • Lichtenstein A; Department of Medicine "B" and Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel.
  • Tiosano S; Tel Aviv University, Sackler School of Medicine, Tel Aviv, Israel.
  • Comaneshter D; Department of Medicine "B" and Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel.
  • Amital H; Tel Aviv University, Sackler School of Medicine, Tel Aviv, Israel.
  • Cohen AD; Chief Physician's Office, Clalit Health Services, Tel Aviv, Israel.
  • Amital D; Department of Medicine "B" and Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel.
Reumatologia ; 56(5): 275-278, 2018.
Article em En | MEDLINE | ID: mdl-30505007
ABSTRACT

BACKGROUND:

The fibromyalgia syndrome (FMS) is a chronic condition consisting of widespread musculoskeletal pain and tenderness together with mood and cognitive dysfunction. Diabetes mellitus (DM) is a common condition causing significant and detrimental morbidity and mortality. Data on the association between the two conditions is scarce and mainly based on small populations therefore lack solid evidence.

OBJECTIVES:

To evaluate the association of FMS with DM. MATERIAL AND

METHODS:

This cross-sectional study used the Clalit Health Services database, the largest Health Maintenance Organization in Israel, serving 4,400,000 members. FMS patients were compared to age- and sex-matched controls regarding chronic comorbid conditions. χ2 and student's t-tests were used for univariate analysis.

RESULTS:

The study included 14,296 FMS patients and 71,324 age- and sex-matched controls. The FMS group had a significantly higher proportion of DM patients compared to non-FMS controls (19.8% and 17.4 respectively; OR 1.17 , 95% CI 1.12-1.23, p < 0.001).

CONCLUSIONS:

DM was found to be more common amongst FMS patients compared to matched controls to suggest that the pathophysiology of DM might lead a patient to develop FMS. Consequently, physicians treating DM patients should be aware of the possible risk and asses for clinical signs of FMS in order to diagnose and treat it in time to better their patients' quality of life and disease management.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Idioma: En Revista: Reumatologia Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Israel

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Idioma: En Revista: Reumatologia Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Israel